메뉴 건너뛰기




Volumn 126, Issue 5, 2010, Pages

Successful treatment of thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus with recombinant human soluble thrombomodulin

Author keywords

[No Author keywords available]

Indexed keywords

DANAPAROID; DOUBLE STRANDED DNA ANTIBODY; LOW MOLECULAR WEIGHT HEPARIN; METHYLPREDNISOLONE; RECOMBINANT THROMBOMODULIN; RECOMODULIN; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

EID: 78149280175     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2010.06.024     Document Type: Letter
Times cited : (11)

References (7)
  • 1
    • 0038318856 scopus 로고    scopus 로고
    • The frequency of thrombotic thrombocytopenic purpura in patients with systemic lupus erythematosus undergoing kidney biopsy
    • A.M. Manadan, C. Harris, M.M. Schwartz, and J.A. Block The frequency of thrombotic thrombocytopenic purpura in patients with systemic lupus erythematosus undergoing kidney biopsy J Rheumatol 30 2003 1227 1230
    • (2003) J Rheumatol , vol.30 , pp. 1227-1230
    • Manadan, A.M.1    Harris, C.2    Schwartz, M.M.3    Block, J.A.4
  • 2
    • 0032696866 scopus 로고    scopus 로고
    • Recombinant thrombomodulin and activated protein C in the treatment of disseminated intravascular coagulation
    • I. Maruyama Recombinant thrombomodulin and activated protein C in the treatment of disseminated intravascular coagulation Thromb Haemost 82 1999 718 721
    • (1999) Thromb Haemost , vol.82 , pp. 718-721
    • Maruyama, I.1
  • 3
    • 33845513582 scopus 로고    scopus 로고
    • Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: Results of a phase III, randomized, double-blind clinical trial
    • H. Saito, I. Maruyama, S. Shimazaki, Y. Yamamoto, N. Aikawa, and R. Ohno Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trial J Thromb Haemost 5 2007 31 41
    • (2007) J Thromb Haemost , vol.5 , pp. 31-41
    • Saito, H.1    Maruyama, I.2    Shimazaki, S.3    Yamamoto, Y.4    Aikawa, N.5    Ohno, R.6
  • 4
    • 77950628343 scopus 로고    scopus 로고
    • Successful treatment of transplantation-associated thrombotic microangiopathy with recombinant human soluble thrombomodulin
    • M. Sakai, T. Ikezoe, K. Bandobashi, K. Togitani, and A. Yokoyama Successful treatment of transplantation-associated thrombotic microangiopathy with recombinant human soluble thrombomodulin Bone Marrow Transplant 45 2010 803 805
    • (2010) Bone Marrow Transplant , vol.45 , pp. 803-805
    • Sakai, M.1    Ikezoe, T.2    Bandobashi, K.3    Togitani, K.4    Yokoyama, A.5
  • 5
    • 77950624556 scopus 로고    scopus 로고
    • Successful treatment of sinusoidal obstructive syndrome after hematopoietic stem cell transplantation with recombinant human soluble thrombomodulin
    • T. Ikezoe, K. Togitani, N. Komatsu, M. Isaka, and A. Yokoyama Successful treatment of sinusoidal obstructive syndrome after hematopoietic stem cell transplantation with recombinant human soluble thrombomodulin Bone Marrow Transplant 45 2010 783 785
    • (2010) Bone Marrow Transplant , vol.45 , pp. 783-785
    • Ikezoe, T.1    Togitani, K.2    Komatsu, N.3    Isaka, M.4    Yokoyama, A.5
  • 6
    • 20944436774 scopus 로고    scopus 로고
    • The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism
    • K. Abeyama, D.M. Stern, Y. Ito, K. Kawahara, Y. Yoshimoto, and M. Tanaka The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism J Clin Invest 115 2005 1267 1274
    • (2005) J Clin Invest , vol.115 , pp. 1267-1274
    • Abeyama, K.1    Stern, D.M.2    Ito, Y.3    Kawahara, K.4    Yoshimoto, Y.5    Tanaka, M.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.